🔗 Share this article

Texas Attorney General Ken Paxton is suing the producers of acetaminophen, claiming the corporations concealed potential risks that the medication presented to children's neurological development.

This legal action follows thirty days after Donald Trump advocated an unproven link between using acetaminophen - referred to as paracetamol - while pregnant and autism in young ones.

Paxton is suing Johnson & Johnson, which formerly manufactured the drug, the exclusive pain medication recommended for pregnant women, and Kenvue, which now manufacturers it.

In a declaration, he claimed they "betrayed America by profiting off of suffering and promoting medication without regard for the dangers."

The manufacturer states there is no credible evidence linking Tylenol to autism.

"These manufacturers misled for generations, intentionally threatening countless individuals to increase profits," the attorney general, a Republican, stated.

Kenvue said in a statement that it was "deeply concerned by the spread of false claims on the safety of acetaminophen and the likely effects that could have on the well-being of women and children in America."

On its online platform, Kenvue also mentioned it had "continuously evaluated the relevant science and there is lacking reliable evidence that indicates a proven link between consuming acetaminophen and autism."

Groups acting on behalf of medical professionals and health professionals concur.

ACOG has declared paracetamol - the main ingredient in Tylenol - is among limited choices for expectant mothers to treat pain and fever, which can create significant medical dangers if left untreated.

"In over twenty years of studies on the consumption of paracetamol in gestation, no reliable research has successfully concluded that the use of acetaminophen in any stage of gestation causes brain development issues in young ones," the association said.

The lawsuit mentions recent announcements from the former administration in asserting the medication is potentially dangerous.

Recently, Trump caused concern from health experts when he instructed expectant mothers to "struggle intensely" not to consume acetaminophen when unwell.

Federal regulators then issued a notice that physicians should contemplate reducing the usage of acetaminophen, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in children has not been proven.

Health Secretary Robert F Kennedy Jr, who manages the FDA, had promised in spring to undertake "comprehensive study program" that would identify the source of autism spectrum disorder in a short period.

But specialists warned that finding a single cause of autism - believed by scientists to be the consequence of a intricate combination of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a form of permanent neurological difference and condition that influences how people experience and relate to the surroundings, and is identified using physician assessments.

In his court filing, the attorney general - a Trump ally who is campaigning for federal office - claims Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the science" around acetaminophen and autism.

The lawsuit seeks to make the firms "destroy any promotional materials" that claims acetaminophen is safe for expectant mothers.

The Texas lawsuit parallels the complaints of a collection of guardians of minors with autism and attention deficit hyperactivity disorder who sued the makers of Tylenol in two years ago.

Judicial authorities dismissed the legal action, declaring research from the family's specialists was not conclusive.